Bio/Pharma Business

HitGen and Nested Therapeutics Sign Research Service Agreement for DNA-Encoded Library

August 16, 2023

HitGen has entered into a research service agreement with Nested Therapeutics for use of HitGen’s DNA-encoded library for drug discovery.

Gilead and Tentarix Strike Three Cancer And Inflammation Partnership Deals

August 16, 2023

Gilead and Tentarix established three multi-year collaborations to discover and develop multi-functional, conditional protein therapeutics for oncology and inflammatory diseases.

Lilly Completes Spate of Acquisitions

August 15, 2023

The completion of three acquisitions of Versanis Bio, Sigilon Therapeutics, and DICE Therapeutics boosts Eli Lilly and Company’s product pipeline in obesity, diabetes, and immunology.

Rakuten Medical Signs Exclusive Licensing Agreement with Hikma for Cancer Treatments in MENA

August 15, 2023

Under the exclusive agreement, Hikma will commercialize products in Rakuten Medical’s pipeline for cancer treatment in the Middle East and North Africa region.

Unpacking Regenerative Medicines and Start-Up Funding with Luis Alvarez

August 14, 2023

Luis Alvarez, PhD, founder of Theradaptive, candidly discusses how his regenerative therapy start-up evolved and secured start-up funding.

United Kingdom Biotech Report Finds 29% Uptick in Funding

August 14, 2023

A report from the UK Bioindustry Association report indicated that biotech venture and public financing rose from £295 million in the first quarter to £382 million in the second quarter.

Cytomos Secures £4 Million to Develop Spectroscopy Platform

August 14, 2023

Cytomos will use the £4 million in funding to develop its dielectric spectroscopy technology.

iTolerance and Northway Biotech Form Manufacturing Pact for Fusion Protein

August 04, 2023

Under a manufacturing agreement, Northway Biotech will develop a manufacturing process for iTolerance’s fusion protein in development for regenerative therapy.

An Intelligent Drug Development Paradigm

August 03, 2023

An intelligent drug development paradigm can enable small pharma to implement an effective early drug development approach.

Charting the Future of Vaccines

August 03, 2023

A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.